bioAffinity (BIAF) news
Recent news
Wallachbeth Capital announces closing of Bioaffinity Technologies $4 million registered direct financing of common stock and concurrent private placement priced at-the-market under Nasdaq rules
Wallachbeth Capital has announced the completion of a $4 million registered direct financing and concurrent private placement for Bioaffinity Technologies. The transaction involves the issuance of common stock priced at-the-market under Nasdaq rules. The offering was conducted through a registered…
AInvest Wire · 6d agoBioaffinity Technologies, Inc. announces closing of $4 million registered direct financing of common stock and concurrent private placement priced at-the-market under Nasdaq rules
Bioaffinity Technologies, Inc. has announced the completion of a $4 million registered direct financing and a concurrent private placement of its common stock, priced at-the-market under Nasdaq rules. The transaction includes the issuance of common shares to accredited investors, with proceeds…
AInvest Wire · 6d agoWallachbeth Capital announces Bioaffinity Technologies approximately $4 million registered direct financing of common stock and concurrent private placement priced at-the-market under Nasdaq rules
bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) has announced a registered direct offering and concurrent private placement of its common stock, raising approximately $4 million in gross proceeds before fees and expenses. The offering, priced at-the-market under Nasdaq rules, involves the sale…
AInvest Wire · 7d agoTrading halted: (BIAF) Due to limit-up limit-down trading pause
Trading in the shares of bioAffinity Technologies Inc. (BIAF) has been temporarily suspended due to a limit-up limit-down trading pause, as reported by market regulators. This type of pause is typically implemented when a stock’s price moves sharply within a short period, triggering circuit…
AInvest Wire · 7d agoBioaffinity Technologies, Inc. announces approximately $4 million registered direct financing of common stock and concurrent private placement priced at-the-market under Nasdaq rules
BioAffinity Technologies, Inc. (NASDAQ: BIAF) has announced the pricing of a $4 million private placement offering of its common stock, conducted at-the-market under Nasdaq rules. The offering includes the sale of 8,462,027 shares of common stock (or pre-funded warrants in lieu thereof) and two…
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.